Drug Industry Daily
Oct. 29, 2012
| Vol.
11 No.
212
FDA: NECC Failed to Fix Problems After Early Warning Signs
The New England Compounding Center (NECC), at the heart of a nationwide fungal meningitis outbreak, dropped the ball after seeing early signs of unacceptable levels of microbial contamination, the FDA says.
This article is viewable by subscribers only. To view this article, please select an option below.
|